Research Council of Norway awards NOK 14M grant to Clavis Pharma for development of hENT1 biomarker assay for targeted therapy of leukaemia patients 01 Jun 2011 News
Kancera enters collaboration with investigators at Northwestern University Feinberg School of Medicine, Chicago, USA, to battle aggressive cancer 12 May 2011 News